Key result
Elevated serum FABP4 levels after stroke are associated with 3-month mortality, suggesting FABP4 as a potential therapeutic target in cardiovascular disorders.
Design
Editorial
Authors
Loading...
This editorial highlights the potential of FABP4 as a novel therapeutic target in ischaemic stroke and cardiovascular diseases due to its role in linking metabolism and inflammation.
This editorial highlights the potential of FABP4 as a novel therapeutic target in ischaemic stroke and cardiovascular diseases due to its role in linking metabolism and inflammation.
Bacigaluppi et al. (2020) conducted an editorial in ischaemic stroke. FABP4 was evaluated. Elevated serum FABP4 levels after stroke are associated with 3-month mortality, suggesting FABP4 as a potential therapeutic target in cardiovascular disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: